<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="In-Process" Owner="NLM">        <PMID Version="1">30259416</PMID>        <DateRevised>            <Year>2018</Year>            <Month>11</Month>            <Day>18</Day>        </DateRevised>        <Article PubModel="Print-Electronic">            <Journal>                <ISSN IssnType="Electronic">2211-3436</ISSN>                <JournalIssue CitedMedium="Internet">                    <Volume>41</Volume>                    <Issue>6</Issue>                    <PubDate>                        <Year>2018</Year>                        <Month>Dec</Month>                    </PubDate>                </JournalIssue>                <Title>Cellular oncology (Dordrecht)</Title>                <ISOAbbreviation>Cell Oncol (Dordr)</ISOAbbreviation>            </Journal>            <ArticleTitle>Emerging ways to treat breast cancer: will promises be met?</ArticleTitle>            <Pagination>                <MedlinePgn>605-621</MedlinePgn>            </Pagination>            <ELocationID EIdType="doi" ValidYN="Y">10.1007/s13402-018-0409-1</ELocationID>            <Abstract>                <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Breast cancer (BC) is the most common cancer among women and it is responsible for more than 40,000 deaths in the United States and more than 500,000 deaths worldwide each year. In previous decades, the development of improved screening, diagnosis and treatment methods has led to decreases in BC mortality rates. More recently, novel targeted therapeutic options, such as the use of monoclonal antibodies and small molecule inhibitors that target specific cancer cell-related components, have been developed. These components include ErbB family members (HER1, HER2, HER3 and HER4), Ras/MAPK pathway components (Ras, Raf, MEK and ERK), VEGF family members (VEGFA, VEGFB, VEGFC, VEGF and PGF), apoptosis and cell cycle regulators (BAK, BAX, BCL-2, BCL-X, MCL-1 and BCL-W, p53 and PI3K/Akt/mTOR pathway components) and DNA repair pathway components such as BRCA1. In addition, long noncoding RNA inhibitor-, microRNA inhibitor/mimic- and immunotherapy-based approaches are being developed for the treatment of BC. Finally, a novel powerful technique called CRISPR-Cas9-based gene editing is emerging as a precise tool for the targeted treatment of cancer, including BC.</AbstractText>                <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Potential new strategies that are designed to specifically target BC are presented. Several clinical trials using these strategies are already in progress and have shown promising results, but inherent limitations such as off-target effects and low delivery efficiencies still have to be resolved. By improving the clinical efficacy of current therapies and exploring new ones, it is anticipated that novel ways to overcome BC may become attainable.</AbstractText>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Samadi</LastName>                    <ForeName>Pouria</ForeName>                    <Initials>P</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Molecular Medicine and Genetics, Research Center for Molecular Medicine, Faculty of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Saki</LastName>                    <ForeName>Sahar</ForeName>                    <Initials>S</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Medical Virology, Faculty of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Dermani</LastName>                    <ForeName>Fatemeh Karimi</ForeName>                    <Initials>FK</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Molecular Medicine and Genetics, Research Center for Molecular Medicine, Faculty of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Pourjafar</LastName>                    <ForeName>Mona</ForeName>                    <Initials>M</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Molecular Medicine and Genetics, Research Center for Molecular Medicine, Faculty of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Saidijam</LastName>                    <ForeName>Massoud</ForeName>                    <Initials>M</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Molecular Medicine and Genetics, Research Center for Molecular Medicine, Faculty of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran. sjam110@yahoo.com.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>                <PublicationType UI="D016454">Review</PublicationType>            </PublicationTypeList>            <ArticleDate DateType="Electronic">                <Year>2018</Year>                <Month>09</Month>                <Day>27</Day>            </ArticleDate>        </Article>        <MedlineJournalInfo>            <Country>Netherlands</Country>            <MedlineTA>Cell Oncol (Dordr)</MedlineTA>            <NlmUniqueID>101552938</NlmUniqueID>            <ISSNLinking>2211-3428</ISSNLinking>        </MedlineJournalInfo>        <CommentsCorrectionsList>            <CommentsCorrections RefType="Cites">                <RefSource>Gynecol Oncol. 2010 Dec;119(3):586-93</RefSource>                <PMID Version="1">20801493</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nat Methods. 2009 Dec;6(12):897-903</RefSource>                <PMID Version="1">19915559</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Invest. 2010 Sep;120(9):3326-39</RefSource>                <PMID Version="1">20697159</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>World J Clin Oncol. 2014 Aug 10;5(3):412-24</RefSource>                <PMID Version="1">25114856</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Cell Physiol. 2018 Sep 7;:null</RefSource>                <PMID Version="1">30191996</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nat Med. 2011 Aug 07;17(9):1101-8</RefSource>                <PMID Version="1">21822286</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Biochem Biophys Res Commun. 2017 Aug 5;489(4):386-392</RefSource>                <PMID Version="1">28552529</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Genomics Proteomics Bioinformatics. 2016 Feb;14(1):42-54</RefSource>                <PMID Version="1">26883671</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Res. 2011 Mar 1;71(5):1550-60</RefSource>                <PMID Version="1">21343399</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Iran Biomed J. 2015;19(1):17-22</RefSource>                <PMID Version="1">25605485</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nat Rev Cancer. 2010 Feb;10(2):147-56</RefSource>                <PMID Version="1">20075923</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer Res Treat. 1999 Sep;57(2):201-6</RefSource>                <PMID Version="1">10598047</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Ann Surg Treat Res. 2015 Jul;89(1):1-8</RefSource>                <PMID Version="1">26131438</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>BMC Med. 2015 Jun 09;13:137</RefSource>                <PMID Version="1">26059247</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Ther Adv Med Oncol. 2015 May;7(3):170-80</RefSource>                <PMID Version="1">26673580</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Cell. 2014 Apr 14;25(4):501-15</RefSource>                <PMID Version="1">24735924</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Oncology (Williston Park). 2016 May;30(5):475-81, 485</RefSource>                <PMID Version="1">27188680</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Ann Oncol. 2006 May;17(5):750-62</RefSource>                <PMID Version="1">16293674</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Apoptosis. 2014 Jul;19(7):1055-68</RefSource>                <PMID Version="1">24756955</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Biol Chem. 2007 May 11;282(19):14328-36</RefSource>                <PMID Version="1">17363372</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Oncotarget. 2015 Nov 3;6(34):35231-46</RefSource>                <PMID Version="1">26497685</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Oncotarget. 2016 May 10;7(19):27055-66</RefSource>                <PMID Version="1">26895472</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Curr Oncol. 2015 Feb;22(1):25-32</RefSource>                <PMID Version="1">25684986</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Gene Ther. 2006 Mar;13(6):496-502</RefSource>                <PMID Version="1">16195701</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cell. 2005 Mar 11;120(5):635-47</RefSource>                <PMID Version="1">15766527</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Chin J Cancer. 2013 Jul;32(7):363-4</RefSource>                <PMID Version="1">23823626</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nature. 2017 Jul 13;547(7662):217-221</RefSource>                <PMID Version="1">28678778</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nature. 2002 Aug 29;418(6901):923-4</RefSource>                <PMID Version="1">12198526</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Genome Biol. 2007;8(5):R76</RefSource>                <PMID Version="1">17493263</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Biol Chem. 2008 Jan 11;283(2):1026-33</RefSource>                <PMID Version="1">17991735</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Sci Signal. 2011 Aug 09;4(186):pt5</RefSource>                <PMID Version="1">21868360</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Blood. 2010 Apr 1;115(13):2630-9</RefSource>                <PMID Version="1">20086245</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Genome Biol. 2007;8(8):R166</RefSource>                <PMID Version="1">17697356</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Onco Targets Ther. 2017 Dec 01;10:5739-5744</RefSource>                <PMID Version="1">29238206</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Expert Opin Ther Targets. 2013 Jan;17(1):61-75</RefSource>                <PMID Version="1">23173842</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Gene. 2013 Nov 15;531(1):8-14</RefSource>                <PMID Version="1">23994196</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Transl Med. 2012 Jun 27;10:134</RefSource>                <PMID Version="1">22738135</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nat Cell Biol. 2007 Jun;9(6):654-9</RefSource>                <PMID Version="1">17486113</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Science. 2007 Oct 12;318(5848):271-4</RefSource>                <PMID Version="1">17761850</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cell Oncol (Dordr). 2017 Aug;40(4):303-339</RefSource>                <PMID Version="1">28748501</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Exp Clin Cancer Res. 2013 Dec 01;32:98</RefSource>                <PMID Version="1">24289849</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>PLoS One. 2013;8(1):e53141</RefSource>                <PMID Version="1">23301032</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>BJU Int. 2014 Aug;114(2):168-76</RefSource>                <PMID Version="1">24215139</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Biol Pharm Bull. 2006 May;29(5):903-6</RefSource>                <PMID Version="1">16651716</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Immun. 2013;13:5</RefSource>                <PMID Version="1">23390376</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer. 2015 May 1;121(9):1369-78</RefSource>                <PMID Version="1">25603785</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Cell. 2008 Nov 4;14(5):369-81</RefSource>                <PMID Version="1">18977326</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Oncotarget. 2016 Aug 9;7(32):52541-52552</RefSource>                <PMID Version="1">27250031</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Oncologist. 2004;9(5):518-27</RefSource>                <PMID Version="1">15477636</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Br J Cancer. 1994 Jul;70(1):120-4</RefSource>                <PMID Version="1">8018521</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>EMBO Rep. 2009 Apr;10(4):400-5</RefSource>                <PMID Version="1">19247375</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Am J Cancer Res. 2015 Sep 15;5(10):2929-43</RefSource>                <PMID Version="1">26693050</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Lett. 2013 Oct 1;339(1):107-15</RefSource>                <PMID Version="1">23879965</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancers (Basel). 2015 Apr 09;7(2):598-616</RefSource>                <PMID Version="1">25860815</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Control Release. 2015 Dec 10;219:632-643</RefSource>                <PMID Version="1">26342659</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>CA Cancer J Clin. 2017 Jan;67(1):7-30</RefSource>                <PMID Version="1">28055103</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Mol Cancer Ther. 2016 Jun;15(6):1364-75</RefSource>                <PMID Version="1">27196750</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer Res. 2010;12(2):201</RefSource>                <PMID Version="1">20346098</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Biol Chem. 2010 Jul 2;285(27):20541-6</RefSource>                <PMID Version="1">20444703</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Biochem Pharmacol. 2010 Mar 15;79(6):817-24</RefSource>                <PMID Version="1">19883630</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer (Auckl). 2015 Sep 01;9(Suppl 1):23-34</RefSource>                <PMID Version="1">26380552</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Adv Drug Deliv Rev. 2007 Mar 30;59(2-3):75-86</RefSource>                <PMID Version="1">17449137</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Biol Chem. 2008 Oct 31;283(44):29897-903</RefSource>                <PMID Version="1">18708351</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Immunol Immunother. 2013 Jun;62(6):1053-60</RefSource>                <PMID Version="1">23595207</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Lancet. 2017 Mar 25;389(10075):1195-1205</RefSource>                <PMID Version="1">28215665</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nature. 2007 Oct 11;449(7163):682-8</RefSource>                <PMID Version="1">17898713</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Biol Chem. 2010 Jun 4;285(23):17869-79</RefSource>                <PMID Version="1">20371610</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Mol Cancer Res. 2013 Mar;11(3):240-50</RefSource>                <PMID Version="1">23339187</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Int J Clin Exp Pathol. 2015 May 01;8(5):4881-91</RefSource>                <PMID Version="1">26191181</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nat Rev Drug Discov. 2013 Jun;12(6):433-46</RefSource>                <PMID Version="1">23722346</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nature. 2004 Sep 16;431(7006):350-5</RefSource>                <PMID Version="1">15372042</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Biol Med. 2015 Dec;12(4):342-54</RefSource>                <PMID Version="1">26779371</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Oncogene. 2014 Jul 31;33(31):4077-88</RefSource>                <PMID Version="1">24037528</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Lancet Oncol. 2018 Jan;19(1):87-100</RefSource>                <PMID Version="1">29223745</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>N Biotechnol. 2010 Jul 31;27(3):243-9</RefSource>                <PMID Version="1">20219708</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cell. 2007 Dec 14;131(6):1109-23</RefSource>                <PMID Version="1">18083101</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cell Oncol (Dordr). 2016 Oct;39(5):397-410</RefSource>                <PMID Version="1">27126599</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer Res Treat. 2008 Jul;110(2):327-35</RefSource>                <PMID Version="1">17851757</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Discov Med. 2014 May;17(95):275-83</RefSource>                <PMID Version="1">24882719</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancers (Basel). 2011 Aug 05;3(3):3114-42</RefSource>                <PMID Version="1">24212948</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Neoplasma. 2013;60(2):135-42</RefSource>                <PMID Version="1">23259781</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nature. 2008 Jan 10;451(7175):147-52</RefSource>                <PMID Version="1">18185580</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Genes Dis. 2014 Sep 1;1(1):53-63</RefSource>                <PMID Version="1">25473652</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nat Commun. 2011;2:282</RefSource>                <PMID Version="1">21505438</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Adv Drug Deliv Rev. 2015 Jan;81:128-41</RefSource>                <PMID Version="1">24859533</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Oncogene. 2016 Apr 14;35(15):1877-87</RefSource>                <PMID Version="1">26257067</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Ann Oncol. 2012 Sep;23 Suppl 10:x207-10</RefSource>                <PMID Version="1">22987963</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>PLoS One. 2017 Jan 3;12(1):e0168669</RefSource>                <PMID Version="1">28045912</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Front Oncol. 2014 Oct 21;4:285</RefSource>                <PMID Version="1">25374842</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>N Engl J Med. 2016 Jun 9;374(23):2287-9</RefSource>                <PMID Version="1">27276568</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Immunology. 2013 Feb;138(2):105-15</RefSource>                <PMID Version="1">23216602</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Biochim Biophys Acta. 2016 Jan;1859(1):3-15</RefSource>                <PMID Version="1">26477492</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Clin Cancer Res. 2002 May;8(5):1014-8</RefSource>                <PMID Version="1">12006513</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Angew Chem Int Ed Engl. 2008;47(39):7482-4</RefSource>                <PMID Version="1">18712719</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Int J Surg Oncol. 2013;2013:875078</RefSource>                <PMID Version="1">23936642</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Eur J Clin Pharmacol. 2014 May;70(5):531-8</RefSource>                <PMID Version="1">24562632</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Clin Exp Pharmacol Physiol. 2016 Aug;43(8):769-76</RefSource>                <PMID Version="1">27161651</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>BMC Med. 2015 Aug 13;13:188</RefSource>                <PMID Version="1">26268938</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Int J Oncol. 2012 Dec;41(6):2119-27</RefSource>                <PMID Version="1">22992757</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Sci Signal. 2012 Sep 25;5(243):ra70</RefSource>                <PMID Version="1">23012657</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Geburtshilfe Frauenheilkd. 2015 Jul;75(7):675-682</RefSource>                <PMID Version="1">26257404</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Mol Cancer. 2011 Sep 22;10:117</RefSource>                <PMID Version="1">21939504</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Oncogene. 2013 May 16;32(20):2555-64</RefSource>                <PMID Version="1">22751119</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Proc Natl Acad Sci U S A. 1998 Dec 22;95(26):15665-70</RefSource>                <PMID Version="1">9861027</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer Res. 2011 Jan 10;13(1):R2</RefSource>                <PMID Version="1">21219636</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Ann Intern Med. 2016 Feb 16;164(4):279-96</RefSource>                <PMID Version="1">26757170</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Eur J Cancer. 2015 Jul;51(10):1212-20</RefSource>                <PMID Version="1">25892646</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Invest. 2013 Jan;123(1):150-63</RefSource>                <PMID Version="1">23241956</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nat Cell Biol. 2008 May;10(5):593-601</RefSource>                <PMID Version="1">18376396</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nat Rev Cancer. 2013 Oct;13(10):714-26</RefSource>                <PMID Version="1">24060863</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nat Rev Cancer. 2015 Jul;15(7):387-95</RefSource>                <PMID Version="1">26040603</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Lett. 2017 Jan 28;385:137-143</RefSource>                <PMID Version="1">27815036</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Pain. 2014 Aug;155(8):1527-39</RefSource>                <PMID Version="1">24792623</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Gene Ther. 2001 Feb;8(4):316-23</RefSource>                <PMID Version="1">11313806</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nat Immunol. 2013 Oct;14(10):1014-22</RefSource>                <PMID Version="1">24048123</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Res. 2010 Apr 15;70(8):3119-27</RefSource>                <PMID Version="1">20354188</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Res. 2011 May 1;71(9):3400-9</RefSource>                <PMID Version="1">21389093</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>PLoS One. 2008 Sep 05;3(9):e3148</RefSource>                <PMID Version="1">18773077</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Oncogene. 2012 Dec 13;31(50):5162-71</RefSource>                <PMID Version="1">22286770</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Zhejiang Univ Sci B. 2015 Jan;16(1):18-31</RefSource>                <PMID Version="1">25559952</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Oncotarget. 2016 Dec 6;7(49):81452-81462</RefSource>                <PMID Version="1">27845892</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>CA Cancer J Clin. 2015 Mar;65(2):87-108</RefSource>                <PMID Version="1">25651787</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>PLoS One. 2013 Apr 24;8(4):e62170</RefSource>                <PMID Version="1">23637992</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cell. 2004 Jan 23;116(2):281-97</RefSource>                <PMID Version="1">14744438</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Cell Biochem. 2015 Jun;116(6):943-53</RefSource>                <PMID Version="1">25559917</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Perspect Clin Res. 2016 Apr-Jun;7(2):68-74</RefSource>                <PMID Version="1">27141472</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Tumour Biol. 2013 Jun;34(3):1361-70</RefSource>                <PMID Version="1">23529451</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cell Oncol (Dordr). 2017 Jun;40(3):199-208</RefSource>                <PMID Version="1">28534212</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Chromosoma. 2009 Aug;118(4):405-18</RefSource>                <PMID Version="1">19340450</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>PLoS One. 2015 Dec 30;10(12):e0145442</RefSource>                <PMID Version="1">26717149</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Cell Sci. 2013 May 15;126(Pt 10):2256-66</RefSource>                <PMID Version="1">23525011</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Res. 2011 Jul 1;71(13):4443-53</RefSource>                <PMID Version="1">21586611</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Curr Drug Targets. 2014 Jan;15(1):17-31</RefSource>                <PMID Version="1">24387337</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Int J Biochem Cell Biol. 2013 Aug;45(8):1895-910</RefSource>                <PMID Version="1">23748105</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Adv Pharm Technol Res. 2010 Apr;1(2):109-26</RefSource>                <PMID Version="1">22247839</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Gastroenterology. 2007 Aug;133(2):647-58</RefSource>                <PMID Version="1">17681183</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Gynecol Oncol. 2008 Jul;110(1):13-21</RefSource>                <PMID Version="1">18589210</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nature. 2005 Dec 1;438(7068):685-9</RefSource>                <PMID Version="1">16258535</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Surg Oncol Clin N Am. 2014 Jul;23(3):567-77</RefSource>                <PMID Version="1">24882351</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Biomed Res Int. 2014;2014:150845</RefSource>                <PMID Version="1">25013758</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Front Endocrinol (Lausanne). 2017 Oct 13;8:270</RefSource>                <PMID Version="1">29081765</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Curr Med Chem. 2013;20(38):4888-923</RefSource>                <PMID Version="1">24059235</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nat Biotechnol. 2014 Apr;32(4):347-55</RefSource>                <PMID Version="1">24584096</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Front Oncol. 2015 Dec 21;5:288</RefSource>                <PMID Version="1">26732534</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Future Med Chem. 2014;6(17):1967-84</RefSource>                <PMID Version="1">25495987</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cell. 2009 Jun 12;137(6):1005-17</RefSource>                <PMID Version="1">19524505</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Biomed Sci. 2013 Oct 24;20:79</RefSource>                <PMID Version="1">24152184</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Hum Gene Ther. 2003 Jul 20;14(11):1117-23</RefSource>                <PMID Version="1">12885350</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Natl Cancer Inst. 2010 Aug 18;102(16):1224-37</RefSource>                <PMID Version="1">20616353</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Immunol Immunother. 2005 Feb;54(2):129-40</RefSource>                <PMID Version="1">15365776</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Biol Chem. 2011 Jul 22;286(29):25992-6002</RefSource>                <PMID Version="1">21596753</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Science. 1992 Nov 27;258(5087):1485-8</RefSource>                <PMID Version="1">1359646</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Int J Environ Res Public Health. 2017 Jan 12;14(1):</RefSource>                <PMID Version="1">28085094</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Sci Rep. 2015 Mar 17;5:9149</RefSource>                <PMID Version="1">25779766</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Front Immunol. 2015 May 20;6:243</RefSource>                <PMID Version="1">26042126</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nature. 2012 Apr 18;486(7403):346-52</RefSource>                <PMID Version="1">22522925</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Maedica (Buchar). 2015 Jun;10(2):185-191</RefSource>                <PMID Version="1">28275416</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Cell Physiol. 2015 Nov;230(11):2683-94</RefSource>                <PMID Version="1">25808524</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Mol Cancer Ther. 2016 Jan;15(1):190-8</RefSource>                <PMID Version="1">26637364</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>PLoS One. 2013 Jun 11;8(6):e66502</RefSource>                <PMID Version="1">23776679</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nat Commun. 2016 Sep 26;7:12791</RefSource>                <PMID Version="1">27666543</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancers (Basel). 2014 Apr 16;6(2):926-57</RefSource>                <PMID Version="1">24743778</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Res. 2007 Nov 15;67(22):10782-8</RefSource>                <PMID Version="1">18006822</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Pharm Res. 2011 Dec;28(12):2996-3015</RefSource>                <PMID Version="1">22033880</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Res. 2005 Aug 15;65(16):7065-70</RefSource>                <PMID Version="1">16103053</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Int J Oncol. 2016 Mar;48(3):869-85</RefSource>                <PMID Version="1">26698230</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Clin Cancer Res. 2002 Nov;8(11):3407-18</RefSource>                <PMID Version="1">12429628</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer Res. 2012 Jun 07;14(3):R89</RefSource>                <PMID Version="1">22676470</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Exp Clin Cancer Res. 2011 Sep 26;30:87</RefSource>                <PMID Version="1">21943236</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Oncotarget. 2015 May 10;6(13):11652-63</RefSource>                <PMID Version="1">25871474</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Gene Ther. 2006 Mar;13(6):541-52</RefSource>                <PMID Version="1">16397510</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Insights Imaging. 2016 Feb;7(1):131-44</RefSource>                <PMID Version="1">26567115</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Lancet. 2015 Oct 3;386(10001):1341-1352</RefSource>                <PMID Version="1">26211827</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Cell Biol. 2011 Oct 31;195(3):417-33</RefSource>                <PMID Version="1">22024162</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Natl Compr Canc Netw. 2013 Jun 1;11(6):670-8</RefSource>                <PMID Version="1">23744866</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Clin Adv Hematol Oncol. 2016 Nov;14(11):922-933</RefSource>                <PMID Version="1">27930644</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Treat Rev. 2014 Jun;40(5):605-13</RefSource>                <PMID Version="1">24529896</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2012 Aug;28(8):789-92</RefSource>                <PMID Version="1">22863580</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer Res. 2014;16(2):206</RefSource>                <PMID Version="1">25032258</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Mol Pharmacol. 2009 Jun;75(6):1374-9</RefSource>                <PMID Version="1">19270061</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>PLoS One. 2014 Apr 16;9(4):e95240</RefSource>                <PMID Version="1">24740415</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Clin Cancer Res. 2016 Apr 1;22(7):1583-91</RefSource>                <PMID Version="1">26563128</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Semin Cancer Biol. 2003 Dec;13(6):409-15</RefSource>                <PMID Version="1">15001159</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Front Oncol. 2014 Apr 14;4:64</RefSource>                <PMID Version="1">24782981</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Expert Opin Drug Deliv. 2009 Jul;6(7):673-86</RefSource>                <PMID Version="1">19552611</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Res. 2016 Mar 1;76(5):1101-11</RefSource>                <PMID Version="1">26747895</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>RNA. 2008 Nov;14(11):2348-60</RefSource>                <PMID Version="1">18812439</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>CA Cancer J Clin. 2017 Nov;67(6):439-448</RefSource>                <PMID Version="1">28972651</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Oncogene. 2016 May;35(21):2746-55</RefSource>                <PMID Version="1">26364613</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Res. 1998 Nov 1;58(21):4902-8</RefSource>                <PMID Version="1">9809997</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cell Oncol (Dordr). 2017 Apr;40(2):105-118</RefSource>                <PMID Version="1">27981507</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Lancet. 2005 May 14-20;365(9472):1687-717</RefSource>                <PMID Version="1">15894097</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Biomed Res Int. 2013;2013:747318</RefSource>                <PMID Version="1">23586058</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Lancet. 2011 Nov 12;378(9804):1680-2</RefSource>                <PMID Version="1">22019143</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Oncotarget. 2016 May 10;7(19):27778-86</RefSource>                <PMID Version="1">27034004</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nat Rev Clin Oncol. 2014 Jan;11(1):24-37</RefSource>                <PMID Version="1">24247168</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Asian Pac J Cancer Prev. 2014;15(15):5993-7</RefSource>                <PMID Version="1">25124562</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Biol Chem. 2011 Dec 16;286(50):43475-85</RefSource>                <PMID Version="1">22020939</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Immunol Immunother. 2004 Jul;53(7):633-41</RefSource>                <PMID Version="1">14985857</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Tumour Biol. 2016 Feb;37(2):1479-85</RefSource>                <PMID Version="1">26662315</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nat Rev Drug Discov. 2010 Oct;9(10):775-89</RefSource>                <PMID Version="1">20885409</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cell Death Dis. 2012 Nov 29;3:e436</RefSource>                <PMID Version="1">23190608</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cell Oncol (Dordr). 2018 Jun;41(3):223-252</RefSource>                <PMID Version="1">29667069</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cell Oncol (Dordr). 2016 Jun;39(3):195-210</RefSource>                <PMID Version="1">27007278</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Oncol Rep. 2016 Nov;36(5):2843-2851</RefSource>                <PMID Version="1">27666541</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nature. 2010 Apr 15;464(7291):1071-6</RefSource>                <PMID Version="1">20393566</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Mol Cancer Ther. 2008 Jul;7(7):2152-9</RefSource>                <PMID Version="1">18645025</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Genes Dev. 2016 Jun 15;30(12):1470-80</RefSource>                <PMID Version="1">27340177</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Int J Cancer. 2013 Apr 1;132(7):1602-12</RefSource>                <PMID Version="1">22927033</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer Res Treat. 2015 Jan;149(1):5-15</RefSource>                <PMID Version="1">25542271</PMID>            </CommentsCorrections>        </CommentsCorrectionsList>        <KeywordList Owner="NOTNLM">            <Keyword MajorTopicYN="N">Breast cancer</Keyword>            <Keyword MajorTopicYN="N">CRISPR-Cas9 editing</Keyword>            <Keyword MajorTopicYN="N">Cancer vaccines</Keyword>            <Keyword MajorTopicYN="N">Immunotherapy</Keyword>            <Keyword MajorTopicYN="N">Long noncoding RNAs</Keyword>            <Keyword MajorTopicYN="N">MicroRNAs</Keyword>            <Keyword MajorTopicYN="N">Small molecule inhibitors</Keyword>            <Keyword MajorTopicYN="N">Targeted therapy</Keyword>        </KeywordList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="accepted">                <Year>2018</Year>                <Month>09</Month>                <Day>13</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>9</Month>                <Day>28</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>9</Month>                <Day>28</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>9</Month>                <Day>28</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>ppublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30259416</ArticleId>            <ArticleId IdType="doi">10.1007/s13402-018-0409-1</ArticleId>            <ArticleId IdType="pii">10.1007/s13402-018-0409-1</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>